Managing the unavoidable: A practical approach to handling TUPs

Technically unavoidable particles (TUPs) are found in chemical raw materials, such as excipients. They do not pose a risk to patient safety, but can create problems if not managed well. Merck KGaA's Dr Torsten Schadendorf and Jennifer Standare explain

picture of

Breaking News

Civica and Thermo Fisher join forces to manufacture drugs in short supply

Thermo Fisher has agreed to produce Civica-owned Abbreviated New Drug Applications to secure the manufacture of certain ...

Evonik acquires US phytochemical supplier

The acquisition of Wilshire Technologies has added a sustainable portfolio of phytochemicals and derivatives for the ...

US gene therapy CDMO enters virus manufacturing partnership

Vigene Biosciences will provide manufacturing services for ASC for both early-stage and commercial virus production

Triton X-100 surfactant joins the list of contaminants of emerging concern

Evidence-based concerns about the environmental consequences of the widespread use of Triton X-100 have prompted calls ...

European collaboration begins development of antibody-based senolytics

Velabs Therapeutics has agreed to work with alytas therapeutics again to develop antibody-based senolytics

WuXi STA opens oligonucleotide large-scale manufacturing facility

API production at the Changzhou site can manufacture oligonucleotide ingredients up to 1 mol/synthesis run

IntelGenX: Oral films are drug development’s patent trick

Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help ...

Creative Peptides launches synthetic peptide APIs in the US

New York-based Creative Peptides has a portfolio of more than 100 peptides and related products available from grams to ...

Colorcon completes multimillion dollar manufacturing expansion

Global excipient supplier has invested in the consolidation of multiple US legacy buildings into one unified ...

Developing and manufacturing accurate and reproducible APIs

The measurement of the refractive index (RI) is employed by a wide variety of industries to determine the level of ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...

The rise of HPAPIs: Putting safety first

The increasing focus on highly potent active pharmaceutical ingredients (HPAPIs) in pharmaceutical development ...

Azelis to enter Latin America with the acquisition of Megafarma

The transaction is expected to be completed within the next month

Swedish biotech chooses Recipharm for sepsis drug manufacturing

Recipharm has signed a deal with Aptahem to develop an injectable formulation for an upcoming Phase 1 study